Internal Medicine, Transplant Hepatology · Shreveport, LA
NPI
1205826419
Since 2005
Specialty
Internal Medicine, Transplant Hepatology
Code 207RT0003X
Group practices
4
Medicare group memberships
Hospitals
3
Hospital affiliations
3217 Mabel St
Shreveport, LA, 71103
Phone (318) 631-9121
Groups this clinician bills Medicare through
Medicare paid, 2024
$506K
14,833 services
Medicare patients, 2024
2,928
Average age 73
Drug cost, 2024
$2.2M
2,062 prescriptions
Company payments, 2025
$1,164
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by David F Dies was code 88305 (surgical pathology examination), 6,448 times for 2,635 patients. In total David F Dies billed 14,833 services in 59 codes, and Medicare paid $506K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-08-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 88305 Surgical Pathology Examination | Office | 6,448 | 2,635 | $23.50 | $151K |
| 88313 Surgical Pathology Examination | Office | 2,599 | 1,285 | $48.56 | $126K |
| 88312 Surgical Pathology Examination | Office | 1,374 | 1,129 | $58.86 | $81K |
| 43239 Upper GI Endoscopy | Facility | 169 | 164 | $71.22 | $12K |
| 76981 Ultrasound - Nonspecific | Office | 116 | 116 | $68.50 | $7,946 |
| 45380 Lower GI Endoscopy - Other | Facility | 103 | 103 | $97.64 | $10K |
| 45385 Colonoscopy - Lesion Removal | Facility | 78 | 78 | $194.38 | $15K |
| 88307 Surgical Pathology Examination | Office | 48 | 47 | $142.97 | $6,863 |
| 43450 Digestive/Gastrointestinal | Facility | 43 | 41 | $26.93 | $1,158 |
| 49082 Digestive/Gastrointestinal | Facility | 38 | 12 | $49.87 | $1,895 |
| 99222 Hospital E&M - Initial | Facility | 32 | 32 | $94.53 | $3,025 |
| 99214 Office E&M - Established | Office | 28 | 28 | $74.16 | $2,076 |
| G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 27 | 27 | $170.89 | $4,614 |
| 99232 Hospital E&M - Subsequent | Facility | 27 | 27 | $57.89 | $1,563 |
| 43244 Upper GI Endoscopy | Facility | 21 | 16 | $167.73 | $3,522 |
By year: 2022 $668K for 17,200 services; 2023 $704K for 18,612 services; 2024 $506K for 14,833 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 88305 Surgical Pathology Examination | 6,448 | 2,635 | $23.50 | $151K |
| 88313 Surgical Pathology Examination | 2,599 | 1,285 | $48.56 | $126K |
| 88312 Surgical Pathology Examination | 1,374 | 1,129 | $58.86 | $81K |
| 88307 Surgical Pathology Examination | 48 | 47 | $142.97 | $6,863 |
Medicare prescription drug claims, 2024
In 2024, the drug David F Dies prescribed most often to Medicare patients was Baclofen, with 294 prescriptions and refills. In total David F Dies wrote 2,062 Medicare prescriptions that cost $2.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Baclofen Generic | 294 | 512 | 84 | $2,686 |
| Pantoprazole Sodium Generic | 193 | 367 | 50 | $2,791 |
| Omeprazole Generic | 161 | 327 | 55 | $1,450 |
| Carvedilol Generic | 121 | 169 | 36 | $745 |
| Spironolactone Generic | 116 | 200 | 35 | $1,422 |
| Ursodiol Generic | 96 | 131 | 23 | $13K |
| Furosemide Generic | 89 | 157 | 26 | $280 |
| Azathioprine Generic | 78 | 142 | 21 | $3,242 |
| Colestipol Hcl Generic | 69 | 145 | 25 | $9,067 |
| Metoclopramide Hcl Generic | 68 | 74 | 27 | $219 |
| Epclusa Sofosbuvir/Velpatasvir | 61 | 61 | 23 | $1.5M |
| Esomeprazole Magnesium Generic | 54 | 94 | 18 | $1,050 |
| Prednisone Generic | 51 | 72 | 11 | $254 |
| Ondansetron Hcl Generic | 44 | 46 | Under 11 | $200 |
| Diphenoxylate-Atropine Diphenoxylate Hcl/Atropine | 41 | 41 | 14 | $515 |
Brand drugs: 271 claims; generic drugs: 1,791 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid David F Dies $1,164 ($1,164 in general payments such as food, travel and fees) from 10 companies. The largest payer was Gilead Sciences, Inc. with $518.
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. GILD | 8 | $518 |
| Boston Scientific Corporation BSX | 1 | $150 |
| Madrigal Pharmaceuticals MDGL | 1 | $139 |
| Mirum Pharmaceuticals, Inc. MIRM | 1 | $122 |
| Abbvie Inc. ABBV | 5 | $81.64 |
| Celltrion USA Inc. 068270.KS | 3 | $80.23 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 2 | $30.52 |
| Novo Nordisk Inc NVO | 1 | $21.97 |
| Genzyme Corporation SNY | 1 | $20.07 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.